Summary
- Current Price
- As of today, HRTX price is $0.33, up +6.45% on
- Current Price All-Time High
- HRTX price is currently -99.97% below its historical high of $1,290.00 set on
- Market Cap
- HRTX current market cap is $63M, down -70.59% year-over-year
- Revenue
- HRTX current annual revenue is $154.90M, up +7.36% year-over-year
- Next Earnings
- The next earnings release for HRTX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Heron Therapeutics, Inc. |
| Ticker | NASDAQ: HRTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | herontx.com |
| Employees | 122 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $0.33 | ||
| Price, 1D Change | +6.45% | |
| $63M | ||
| - | ||
| - | ||
| 1.75 | ||
| $154.90M | ||
| Revenue, 1Y Change | +7.36% | |
| -$0.12 | ||
| EPS, 1Y Change | -35.91% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | APPA | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.12 | ||
| EPS Estimate | -$0.13 | N/A |
| EPS Est. Change | -7.35% | N/A |
| $154.90M | ||
| Revenue Estimate | $148.25M | N/A |
| Revenue Est. Change | -4.30% | N/A |
| $0.33 | ||
| Price Target | $7.00 | - |
| Price Tgt. Change | +2,021.21% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.12 | -$0.09 | +25.75% | |
| -$0.05 | -$0.12 | -142.20% | |
| -$0.13 | N/A | -7.35% | |
| -$0.11 | N/A | +9.17% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $140.87M | $144.29M | +2.43% | |
| $153.87M | $154.90M | +0.67% | |
| $148.25M | N/A | -4.30% | |
| $145.90M | N/A | -5.81% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -76.26% | ||
| -80.24% | ||
| -70.59% | ||
| -68.73% | ||
| +7.36% | ||
| +43.87% | ||
| -35.91% | ||
| +92.76% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $0.33 | ||
| $0.91 | ||
| $0.42 | ||
| $0.85 | ||
| $0.45 | ||
| -$0.04 | ||
| 1.75 | ||
| $0.04 | ||
| 37.16 | ||
| 66.02% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $154.90M | ||
| -$0.12 | ||
| $0.00 | ||
| 73.31% | ||
| -$2.54M | ||
| -1.64% | ||
| -$20.20M | ||
| -13.04% | ||
| -$224.00K |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 9.81 | ||
| 2.48 | ||
| 1.51 | ||
| - | ||
| 2 | ||
| -3.51 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 0.41 | ||
| 10.69 | ||
| -19.97 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $13.28M | ||
| $46.63M | ||
| $670.88M | ||
| $238.07M | ||
| $656.54M | ||
| $96.10M | ||
| $140.64M | ||
| $0.00 | ||
| $8.99M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $175.10M | ||
| $116.10M | ||
| $41.35M | ||
| $103.67M | ||
| $2.31M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$27.59M | ||
| $16.01M | ||
| $14.43M | ||
| $317.00K | ||
| -$27.91M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| Needham | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Needham | → | |
| HC Wainwright & Co. | ||
| Needham | → | |
| Needham | → | |
| Needham | → | |
| Needham | → |
Analyst sentiment
Institutional ownership
No data
Screeners with HRTX
FAQ
- What is the ticker symbol for Heron Therapeutics, Inc.?
- The ticker symbol for Heron Therapeutics, Inc. is NASDAQ:HRTX
- Does Heron Therapeutics, Inc. pay dividends?
- No, Heron Therapeutics, Inc. does not pay dividends
- What sector is Heron Therapeutics, Inc. in?
- Heron Therapeutics, Inc. is in the Healthcare sector
- What industry is Heron Therapeutics, Inc. in?
- Heron Therapeutics, Inc. is in the Biotechnology industry
- What country is Heron Therapeutics, Inc. based in?
- Heron Therapeutics, Inc. is headquartered in United States
- When did Heron Therapeutics, Inc. go public?
- Heron Therapeutics, Inc. initial public offering (IPO) was on August 26, 1987
- Is Heron Therapeutics, Inc. in the S&P 500?
- No, Heron Therapeutics, Inc. is not included in the S&P 500 index
- Is Heron Therapeutics, Inc. in the NASDAQ 100?
- No, Heron Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Heron Therapeutics, Inc. in the Dow Jones?
- No, Heron Therapeutics, Inc. is not included in the Dow Jones index
- When was Heron Therapeutics, Inc. last earnings report?
- Heron Therapeutics, Inc.'s most recent earnings report was on August 10, 2026
- When does Heron Therapeutics, Inc. report earnings?
- The next expected earnings date for Heron Therapeutics, Inc. is November 3, 2026
Data Sources & References
- HRTX Official Website www.herontx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/818033/000119312526073515/0001193125-26-073515-index.htm
- HRTX Profile on Yahoo Finance finance.yahoo.com/quote/HRTX
- HRTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/hrtx